1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Felizmenio-Quimio, M.E. Daly, N.L. Craik, D.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 276 22875 22882 10.1074/jbc.M101666200 11292835 Circular proteins in plants: solution structure of a novel macrocyclic trypsin inhibitor from Momordica cochinchinensis. 2001 10.2210/pdb1ib9/pdb pdb_00001ib9 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 3483.040 TRYPSIN INHIBITOR II 1 nat polymer MCOTI-II no no SGSDGGVCPKILKKCRRDSDCPGACICRGNGYCG SGSDGGVCPKILKKCRRDSDCPGACICRGNGYCG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n spiny bitter cucumber THE PROTEIN IS ISOLATED FROM THE SEEDS USING SODIUM ACETATE. Momordica sample 3674 Momordica cochinchinensis database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Other Data collection Database references Derived calculations 1 0 2001-07-18 1 1 2008-04-27 1 2 2011-07-13 1 3 2013-02-27 1 4 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model RCSB Y RCSB 2001-03-28 REL REL Antimicrobial, Antitumor CYCLIC KNOTTIN TRYPSIN INHIBITOR II Cyclic peptide The submitted conformer models are those with the fewest number of restraint violations. 50 20 2D NOESY DQF-COSY E-COSY 3.5 ambient 293 K The structures are based on a total of 420 restraints, 383 are NOE-derived, 25 dihedral angle restraints and 12 from hydrogen bonds. torsion angle dynamics 17 lowest energy 1 mM MCoTI-II, 90% H2O, 10% D2O 90% H2O/10% D2O Bruker collection XwinNMR 2.6 Eccles, Guntert, Billeter, and Wuthrich data analysis XEASY 1.3.7 Guntert, Mumenthaler, and Wuthrich structure solution DYANA 1.5 Brunger structure solution X-PLOR 3.851 Brunger refinement X-PLOR 3.851 750 Bruker AVANCE SER 1 n 1 SER 1 A GLY 2 n 2 GLY 2 A SER 3 n 3 SER 3 A ASP 4 n 4 ASP 4 A GLY 5 n 5 GLY 5 A GLY 6 n 6 GLY 6 A VAL 7 n 7 VAL 7 A CYS 8 n 8 CYS 8 A PRO 9 n 9 PRO 9 A LYS 10 n 10 LYS 10 A ILE 11 n 11 ILE 11 A LEU 12 n 12 LEU 12 A LYS 13 n 13 LYS 13 A LYS 14 n 14 LYS 14 A CYS 15 n 15 CYS 15 A ARG 16 n 16 ARG 16 A ARG 17 n 17 ARG 17 A ASP 18 n 18 ASP 18 A SER 19 n 19 SER 19 A ASP 20 n 20 ASP 20 A CYS 21 n 21 CYS 21 A PRO 22 n 22 PRO 22 A GLY 23 n 23 GLY 23 A ALA 24 n 24 ALA 24 A CYS 25 n 25 CYS 25 A ILE 26 n 26 ILE 26 A CYS 27 n 27 CYS 27 A ARG 28 n 28 ARG 28 A GLY 29 n 29 GLY 29 A ASN 30 n 30 ASN 30 A GLY 31 n 31 GLY 31 A TYR 32 n 32 TYR 32 A CYS 33 n 33 CYS 33 A GLY 34 n 34 GLY 34 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ILE 26 A O ILE 26 A N GLY 34 A N GLY 34 1 A A N C SER GLY 1 34 1.31 2 A A N C SER GLY 1 34 1.31 3 A A N C SER GLY 1 34 1.31 4 A A N C SER GLY 1 34 1.31 5 A A N C SER GLY 1 34 1.31 6 A A N C SER GLY 1 34 1.32 7 A A N C SER GLY 1 34 1.31 8 A A N C SER GLY 1 34 1.31 9 A A N C SER GLY 1 34 1.32 10 A A N C SER GLY 1 34 1.31 11 A A N C SER GLY 1 34 1.31 12 A A N C SER GLY 1 34 1.31 13 A A N C SER GLY 1 34 1.31 14 A A N C SER GLY 1 34 1.31 15 A A N C SER GLY 1 34 1.31 16 A A N C SER GLY 1 34 1.31 17 A A N C SER GLY 1 34 1.31 18 A A N C SER GLY 1 34 1.31 19 A A N C SER GLY 1 34 1.31 20 A A N C SER GLY 1 34 1.31 8 A A CYS PRO 8 9 142.11 1 8.75 1.10 114.20 122.95 A A A CA CB SG CYS CYS CYS 33 33 33 N 2 10.64 1.10 114.20 124.84 A A A CA CB SG CYS CYS CYS 33 33 33 N 3 8.06 1.10 114.20 122.26 A A A CA CB SG CYS CYS CYS 33 33 33 N 4 8.72 1.10 114.20 122.92 A A A CA CB SG CYS CYS CYS 33 33 33 N 5 8.53 1.10 114.20 122.73 A A A CA CB SG CYS CYS CYS 33 33 33 N 6 9.71 1.10 114.20 123.91 A A A CA CB SG CYS CYS CYS 33 33 33 N 7 8.40 1.10 114.20 122.60 A A A CA CB SG CYS CYS CYS 33 33 33 N 8 10.57 1.10 114.20 124.77 A A A CA CB SG CYS CYS CYS 33 33 33 N 9 8.61 1.10 114.20 122.81 A A A CA CB SG CYS CYS CYS 33 33 33 N 10 10.77 1.10 114.20 124.97 A A A CA CB SG CYS CYS CYS 33 33 33 N 11 11.39 1.10 114.20 125.59 A A A CA CB SG CYS CYS CYS 33 33 33 N 12 9.77 1.10 114.20 123.97 A A A CA CB SG CYS CYS CYS 33 33 33 N 13 10.68 1.10 114.20 124.88 A A A CA CB SG CYS CYS CYS 33 33 33 N 14 8.94 1.10 114.20 123.14 A A A CA CB SG CYS CYS CYS 33 33 33 N 15 10.22 1.10 114.20 124.42 A A A CA CB SG CYS CYS CYS 33 33 33 N 16 9.34 1.10 114.20 123.54 A A A CA CB SG CYS CYS CYS 33 33 33 N 17 10.71 1.10 114.20 124.91 A A A CA CB SG CYS CYS CYS 33 33 33 N 18 8.55 1.10 114.20 122.75 A A A CA CB SG CYS CYS CYS 33 33 33 N 19 10.54 1.10 114.20 124.74 A A A CA CB SG CYS CYS CYS 33 33 33 N 20 9.15 1.10 114.20 123.35 A A A CA CB SG CYS CYS CYS 33 33 33 N 1 A PRO 9 -70.48 -159.81 1 A LEU 12 -162.64 24.26 1 A CYS 33 -40.69 159.81 2 A LYS 10 -59.04 108.14 2 A LEU 12 -107.27 41.56 3 A LEU 12 -87.19 36.78 3 A CYS 33 -37.71 164.91 4 A PRO 9 -68.98 -167.89 4 A LEU 12 -94.84 46.02 4 A CYS 33 -37.31 155.39 5 A SER 3 -150.25 -136.00 5 A PRO 9 -54.62 102.24 5 A LYS 10 -63.65 83.12 5 A ILE 26 -122.91 -168.54 5 A CYS 33 -40.93 154.73 6 A ASP 4 69.33 -22.88 6 A PRO 9 -65.01 -161.12 6 A LEU 12 -173.79 21.25 6 A CYS 33 -41.14 153.23 7 A SER 3 -89.91 -133.33 7 A LEU 12 -89.83 38.32 7 A CYS 33 -39.95 153.44 8 A PRO 9 -56.45 87.35 8 A LEU 12 -86.13 39.77 8 A CYS 33 -46.10 150.10 9 A SER 3 -150.29 -48.83 9 A ILE 26 -131.04 -159.99 9 A CYS 33 -40.62 158.10 10 A SER 3 -142.32 -16.67 10 A VAL 7 -92.16 44.12 10 A LEU 12 -104.96 49.60 10 A CYS 33 -46.78 161.15 11 A SER 19 -86.75 32.52 11 A CYS 33 -48.43 153.89 12 A SER 3 -150.56 -152.76 12 A VAL 7 -90.06 37.86 12 A PRO 9 -64.35 -157.81 12 A LYS 10 -143.18 33.00 12 A SER 19 -79.62 20.88 12 A CYS 33 -47.60 157.24 13 A SER 3 -89.78 -148.02 13 A PRO 9 -64.20 95.41 13 A LEU 12 -67.30 81.96 13 A CYS 33 -44.49 154.35 14 A CYS 33 -41.22 152.29 15 A LYS 14 -36.32 144.40 15 A ARG 16 -91.48 -63.46 15 A ARG 28 -59.08 170.04 16 A PRO 9 -79.67 28.03 16 A LEU 12 -62.96 70.25 16 A ILE 26 -121.31 -169.78 17 A SER 3 -89.47 -115.29 17 A VAL 7 -94.24 48.85 18 A SER 3 -150.99 -127.18 18 A LEU 12 -86.65 39.43 18 A ILE 26 -130.94 -159.93 18 A CYS 33 -36.03 148.25 19 A SER 3 -150.36 -135.22 19 A VAL 7 -92.22 48.65 19 A LEU 12 -103.73 47.30 19 A CYS 25 -49.30 151.73 19 A CYS 33 -48.67 152.93 20 A VAL 7 -93.62 46.48 20 A LEU 12 -67.70 86.33 SOLUTION STRUCTURE OF MCOTI-II, A MACROCYCLIC TRYPSIN INHIBITOR 1 N N A ARG 17 A ARG 17 HELX_P A CYS 21 A CYS 21 5 1 5 disulf 2.016 A CYS 8 A SG CYS 8 1_555 A CYS 25 A SG CYS 25 1_555 disulf 2.018 A CYS 15 A SG CYS 15 1_555 A CYS 27 A SG CYS 27 1_555 disulf 2.014 A CYS 21 A SG CYS 21 1_555 A CYS 33 A SG CYS 33 1_555 PLANT PROTEIN Cyclic cystine knot, cyclotide, circular protein, beta-hairpin, PLANT PROTEIN ITR2_MOMCO UNP 1 1 P82409 SGSDGGVCPKILKKCRRDSDCPGACICRGNGYCG 1 34 1IB9 1 34 P82409 A 1 1 34 2 anti-parallel A ILE 26 A ILE 26 A CYS 27 A CYS 27 A CYS 33 A CYS 33 A GLY 34 A GLY 34